Avian Influenza
📧 Sign up to get email alerts when something new happens for Avian Influenza.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety and immunogenicity of a monovalent inactivated influenza A (H5N8) vaccine in adults and older adults i…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults [Phase 1]
This clinical trial update describes a Phase 1 study assessing the safety and immunogenicity of two doses of a novel H5 central antigen mRNA…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart [Phase 4]
A Phase 4 clinical trial evaluating the immunogenicity and safety of two doses of an Avian influenza A (H5N1) vaccine given 3 or 8 weeks apa…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial) [Phase 3]
Phase 3 clinical trial update for a pandemic influenza vaccine tested in organ transplant recipients; recruitment is ongoing.
-
EMA approval · 2025-06-27EMA Authorised: Zoonotic Influenza Vaccine Seqirus (A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)) — Seqirus S.r.l.
The European Medicines Agency authorised Seqirus S.r.l.'s Zoonotic Influenza Vaccine for the A/Astrakhan/3212/2020 (H5N8)-like strain (clade…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology [Phase 1]
Phase 1 study in healthy adults comparing an H5N8 influenza vaccine formulated with or without AS03 or MF59 adjuvants; the trial has complet…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses [Phase 2]
Phase 2 trial results comparing H7N9 vaccination with AS03 adjuvant versus unadjuvanted H3N2v vaccination, including standard and systems bi…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: 2013/2017 H7N9 Prime-Boost Interval [Phase 2]
Phase 2 trial update on H7N9 prime-boost interval; completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: 2017 A/H7N9 IIV Revaccination [Phase 2]
Phase 2 trial update on revaccination with A/H7N9 influenza vaccine shows completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza [Phase 2]
Phase 2 safety and efficacy trial of Seqirus A/H7N9 inactivated influenza vaccine with or without MF59 adjuvant for avian influenza preventi…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly [Phase 2]
Phase 2 trial evaluating Sanofi's H7N9 influenza vaccine with and without AS03 adjuvant in adults and elderly has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 [Phase 2]
Phase 2 trial update on co-administration of AS03 adjuvanted A/H7N9 inactivated influenza vaccine with a standard influenza vaccine (IIV4) c…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Safety Trial of Live Attenuated Influenza (H7N3) Vaccine [Phase 1]
Phase 1 safety trial of a live attenuated H7N3 influenza vaccine completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Safety and Immunogenicity Study of IVACFLU-A/H5N1 [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating IVACFLU-A/H5N1 for avian influenza with safety and immunogenicity data.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age [Phase 3]
Phase 3 study evaluating safety, immunogenicity, and lot-to-lot consistency of an H5N1 subunit influenza vaccine in adults; results were pos…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: H7N9 Mix and Match With MF59 in Healthy Elderly Persons [Phase 2]
Phase 2 trial evaluating an H7N9 influenza vaccine with MF59 adjuvant in healthy elderly adults; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects [Phase 2]
Phase 2 trial assessing safety and immunogenicity of two doses of an MF59-adjuvanted monovalent influenza vaccine using an H5N1 surface anti…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of two doses of an MF59C.1-adjuvanted monovalent H5N1 influenza vaccine in adults and eld…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines [Phase 2]
A Phase 2 trial evaluating safety and immunogenicity of two doses of an H5N1 influenza vaccine in adults primed with adjuvanted or non-adjuv…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine [Phase 2]
Phase 2 trial evaluating the safety and immunogenicity of a booster dose of the H5N1 influenza vaccine; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine [Phase 3]
A Phase 3 trial evaluated the safety and immunogenicity of two doses of aH5N1 Monovalent H5N1 Influenza Vaccine in adults and elderly subjec…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults [Phase 1, Phase 2]
A Phase 1/2 trial update evaluating the immunogenicity and safety of a single prime-boost schedule for an H5N1 influenza vaccine in adults.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents [Phase 1, Phase 2]
Phase 1/2 safety and immunogenicity study of a Vero cell-derived, whole-virus H5N1 influenza vaccine in healthy infants, children, and adole…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine [Phase 2]
Phase 2 trial by Mahidol University evaluating whether priming with the PLAI vaccine enhances the immune response to a subsequent inactivate…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Immunogenicity of ND1.1 by Delivery Directly to the Ileum [Phase 1]
Phase 1 trial assessing the immunogenicity of ND1.1 delivered directly to the ileum for Avian influenza has completed. The study was sponsor…